1. Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
    Theoharis C. Theoharides et al, 2021, BioFactors CrossRef
  2. Cognitive-enhancing and antioxidant activities of the aqueous extract from Markhamia tomentosa (Benth.) K. Schum. stem bark in a rat model of scopolamine
    Radu Ionita et al, 2017, Behavioral and Brain Functions CrossRef
  3. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease
    Veerta Sharma et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  4. Vanillic acid attenuates amyloid β1-40-induced long-term potentiation deficit in male rats: an in vivo investigation
    Nesa Ahmadi et al, 2021, Neurological Research CrossRef
  5. Role of Natural Plant Products Against Alzheimer’s Disease
    Himanshi Varshney et al, 2021, CNS & Neurological Disorders - Drug Targets CrossRef
  6. Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
    Alejandro Delgado et al, 2021, BioFactors CrossRef
  7. Natural product for the treatment of Alzheimer’s disease
    Thanh Tung Bui et al, 2017, Journal of Basic and Clinical Physiology and Pharmacology CrossRef
  8. Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer’s Disease
    Fahad Ali et al, 2019, CNS & Neurological Disorders - Drug Targets CrossRef
  9. The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review
    Zeinab Ashaari et al, 2018, Journal of Molecular Neuroscience CrossRef
  10. Prolong treatment with Trans-ferulic acid mitigates bioenergetics loss and restores mitochondrial dynamics in streptozotocin-induced sporadic dementia of Alzheimer's type
    Mohd Faraz Zafeer et al, 2019, NeuroToxicology CrossRef
  11. Isolation and Quantitative Analysis of BACE1 Inhibitory Compounds from Cirsium maackii Flower
    Grishma Bhatarrai et al, 2019, Natural Product Sciences CrossRef
  12. Luteolin Protects Pheochromocytoma (PC-12) Cells against Aβ25-35-Induced Cell Apoptosis through the ER/ERK/MAPK Signalling Pathway
    Han-Rui Wang et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  13. Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer’s Disease: A Review
    Hui Xu et al, 2021, Journal of Agricultural and Food Chemistry CrossRef
  14. The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies
    Ana C. Silveira et al, 2019, Current Neuropharmacology CrossRef
  15. Long-term Dietary Flavonoid Intake and Subjective Cognitive Decline in US Men and Women
    Tian-Shin Yeh et al, 2021, Neurology CrossRef
  16. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
    Md. Sahab Uddin et al, 2020, Molecules CrossRef
  17. Amelioration by nitric oxide (NO) mimetics on neurobehavioral and biochemical changes in experimental model of Alzheimer’s disease in rats
    Harikesh Dubey et al, 2018, NeuroToxicology CrossRef
  18. Critical Review of the Alzheimer’s Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
    Julio A. Flores-Cuadra et al, 2021, Journal of Alzheimer's Disease CrossRef
  19. Potential neuroprotective activity of Mentha longifolia L. in aluminum chloride‐induced rat model of Alzheimer’s disease
    Salma Elshamy et al, 2021, Journal of Food Biochemistry CrossRef
  20. Streptozotocin inhibits synaptic transmission and edaravone attenuates streptozotocin-induced electrophysiological changes in CA1 pyramidal neurons of rat hippocampal slices
    Ting Ju et al, 2016, NeuroToxicology CrossRef
  21. Phytochemicals and cognitive health: Are flavonoids doing the trick?
    Ioannis Bakoyiannis et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  22. Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
    Stephanie Andrade et al, 2019, International Journal of Molecular Sciences CrossRef
  23. Role of natural products for the treatment of Alzheimer's disease
    Tayebeh Noori et al, 2021, European Journal of Pharmacology CrossRef
  24. Novel extraction techniques and pharmaceutical activities of luteolin and its derivatives
    Muhammad Faisal Manzoor et al, 2019, Journal of Food Biochemistry CrossRef
  25. Citrus hystrix-derived 3,7-dimethyloct-6-enal and 3,7-dimethyloct-6-enyl acetate ameliorate acetylcholine deficits
    Shreesh Raj Sammi et al, 2016, RSC Advances CrossRef
  26. Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
    Jing Zhao et al, 2020, Frontiers in Molecular Neuroscience CrossRef
  27. Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer’s Disease
    Agnieszka Jankowska et al, 2020, Current Medicinal Chemistry CrossRef
  28. Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?
    Santa Cirmi et al, 2016, Molecules CrossRef
  29. Intracerebroventricular Streptozotocin as a Model of Alzheimer’s Disease: Neurochemical and Behavioral Characterization in Mice
    Katherine Garcia Ravelli et al, 2017, Neurotoxicity Research CrossRef
  30. Ameliorative effect of supercritical fluid extract of Chrysanthemum indicum Linnén against D-galactose induced brain and liver injury in senescent mice via suppression of oxidative stress, inflammation and apoptosis
    Xie Zhang et al, 2019, Journal of Ethnopharmacology CrossRef
  31. Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives
    Gagandeep Maan et al, 2020, Current Topics in Medicinal Chemistry CrossRef
  32. Quantitative Analysis and Biological Efficacies regarding the Neuroprotective and Antineuroinflammatory Actions of the Herbal Formula Jodeungsan in HT22 Hippocampal Cells and BV-2 Microglia
    Yu Jin Kim et al, 2017, Evidence-Based Complementary and Alternative Medicine CrossRef
  33. Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer’s and Parkinson’s Diseases: An Update of Recent Data
    Ghulam Hussain et al, 2018, Molecules CrossRef
  34. Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer’s disease
    Hamidreza Komaki et al, 2019, Brain Research Bulletin CrossRef
  35. Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT
    Stephanie Dabo et al, 2017, Scientific Reports CrossRef
  36. Myricetin protects hippocampal CA3 pyramidal neurons and improves learning and memory impairments in rats with Alzheimer's disease
    Matin Ramezani et al, 2016, Neural Regeneration Research CrossRef
  37. Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats
    Weiwei Yang et al, 2021, Pregnancy Hypertension CrossRef
  38. Inhibition of α-Synuclein contributes to the ameliorative effects of dietary flavonoids luteolin on arsenite-induced apoptotic cell death in the dopaminergic PC12 cells
    Yi Wu et al, 2017, Toxicology Mechanisms and Methods CrossRef
  39. Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead
    Devendra Kumar et al, 2018, European Journal of Medicinal Chemistry CrossRef
  40. Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment
    Roberta Mancuso et al, 2019, Expert Review of Anti-infective Therapy CrossRef
  41. Nutraceuticals in Neurological Disorders
    Rashita Makkar et al, 2020, International Journal of Molecular Sciences CrossRef
  42. Dietary phytochemicals that influence gut microbiota: Roles and actions as anti-Alzheimer agents
    Yi Wang et al, 2021, Critical Reviews in Food Science and Nutrition CrossRef
  43. Neuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals
    Andleeb Khan et al, 2020, Biomedicines CrossRef
  44. Biophenols
    Syed Haris Omar, 2018, Discovery and Development of Neuroprotective Agents from Natural Products CrossRef
  45. Lavandula angustifolia biological characteristics: An in vitro study
    Masoud Soheili et al, 2019, Journal of Cellular Physiology CrossRef
  46. Luteolin Inhibits Fibrillary β-Amyloid1–40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways
    Jun-Xia Zhang et al, 2017, Molecules CrossRef
  47. Nootropics, Functional Foods, and Dietary Patterns for Prevention of Cognitive Decline
    Francesco Bonetti et al, 2017, Nutrition and Functional Foods for Healthy Aging CrossRef
  48. IKKβ and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD
    Ali Khoshnan et al, 2017, Human Molecular Genetics CrossRef
  49. Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease
    Youngjoo Kwon, 2017, Experimental Gerontology CrossRef
  50. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease
    Zheyu Zhang et al, 2020, Journal of Ethnopharmacology CrossRef
  51. The ameliorative effects of myricetin on neurobehavioral activity, electrophysiology, and biochemical changes in an animal model of traumatic brain injury
    Mohammad Ali Mirshekar et al, 2019, Learning and Motivation CrossRef
  52. Luteolin mitigates tamoxifen-associated fatty liver and cognitive impairment in rats by modulating beta-catenin
    Rana K. El-Asfar et al, 2021, European Journal of Pharmacology CrossRef
  53. Potential of Sorghum Polyphenols to Prevent and Treat Alzheimer’s Disease: A Review Article
    Nasim Rezaee et al, 2021, Frontiers in Aging Neuroscience CrossRef